Taking into account these findings along with the potential novel treatments for COVID-19, such as manipulation of ACE2 receptor, the existing data on TMPRSS2-targeted treatments can be considered as a promising route of therapeutics that can be further investigated. This evidence concerns the gene TMPRSS2 and COVID-19.